Preferred Label : cysteamine;

MeSH definition : A mercaptoethylamine compound that is endogenously derived from the COENZYME A degradative pathway. The fact that cysteamine is readily transported into LYSOSOMES where it reacts with CYSTINE to form cysteine-cysteamine disulfide and CYSTEINE has led to its use in CYSTINE DEPLETING AGENTS for the treatment of CYSTINOSIS.;

MeSH synonym : beta mercaptoethylamine; mercamine; Mercaptamine; 2 aminoethanethiol; beta-mercaptoethylamine; cysteinamine; 2-aminoethanethiol; mercaptoethylamine;

CISMeF synonym : 156-57-0 (Cysteamine hydrochloride);

MeSH hyponym : cysteamine, 35S-Labeled; cysteamine bitartrate; cystagon; cysteamine hydrobromide; becaptan; Cysteamine Maleate (1:1); cysteamine tosylate; cysteamine dihydrochloride; cysteamine hydrochloride; Bitartrate, Cysteamine; Cysteamine Tartrate (1:1); Cysteamine Tartrate; Tartrate, Cysteamine; Dihydrochloride, Cysteamine; Hydrochloride, Cysteamine; Tosylate, Cysteamine; 35S-Labeled Cysteamine; Cysteamine, 35S Labeled; Hydrobromide, Cysteamine;

MeSH CAS label : ethanethiol, 2-amino-;

MeSH Related Number : cysteamine dihydrochloride; cysteamine tartrate (1:1); cysteamine hydrochloride; cysteamine tartrate; cysteamine tosylate; cysteamine maleate (1:1); cysteamine, 35S-Labeled; cysteamine hydrobromide; 156-57-0 (HCl); 16904-32-8 (di-HCl); 18594-39-3 (tartrate); 27761-19-9 (tartrate (1:1)); 3037-04-5 (tosylate); 42954-15-4 (HBr); 55707-28-3 (35S-labeled); 60-23-1 (Cysteamine); 93965-19-6 (maleate (1:1)); cysteamine bitartrate; IF1B771SVB; QO84GZ3TST;

Registry Number MeSH : 60-23-1;

Related CAS MeSH : 16904-32-8 (Cysteamine dihydrochloride); 27761-19-9 (Cysteamine tartrate (1:1)); 18594-39-3 (Cysteamine tartrate); 3037-04-5 (Cysteamine tosylate); 93965-19-6 (Cysteamine maleate (1:1)); 55707-28-3 (Cysteamine, 35S-Labeled); 42954-15-4 (Cysteamine hydrobromide); QO84GZ3TST (Cysteamine bitartrate); IF1B771SVB (Cysteamine hydrochloride);

MeSH annotation : do not confuse with CYSTAMINE;

Wikipedia link : https://en.wikipedia.org/wiki/Cysteamine;

Codes EINECS : 200-463-0;

Is substance : O;

medicament (CISMeF) : O;

UNII : 5UX2SD1KE2;

InChIKey : UFULAYFCSOUIOV-UHFFFAOYSA-N;

Details


Main resources

You can consult :

A mercaptoethylamine compound that is endogenously derived from the COENZYME A degradative pathway. The fact that cysteamine is readily transported into LYSOSOMES where it reacts with CYSTINE to form cysteine-cysteamine disulfide and CYSTEINE has led to its use in CYSTINE DEPLETING AGENTS for the treatment of CYSTINOSIS.

https://www.has-sante.fr/portail/jcms/c_2867367/fr/cystinose
2018
false
false
false
France
French
cystinosis
practice guideline
cystinosis
cystinosis
cysteamine
child
adult
watchful waiting
cystinosis
Cystine Depleting Agents
adolescent

---
https://www.has-sante.fr/portail/jcms/c_2818010/fr/cystadrops
https://www.has-sante.fr/portail/jcms/c_2818010/fr/cystadrops-chlorhydrate-de-mercaptamine-cysteamine-medicament-ophtalmologique
2017
false
false
false
France
French
cysteamine
administration, ophthalmic
treatment outcome
orphan drug production
mercaptamine
child
ophthalmic solutions
adult
evaluation of the transparency committee
adolescent
Corneal deposit associated with metabolic disorder (disorder)
corneal diseases
Cystine Depleting Agents
ocular cystinosis
guidelines for drug use
cysteamine
cystinosis
cystinosis

---
https://www.ema.europa.eu/medicines/human/EPAR/Cystadrops
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
cysteamine
administration, ophthalmic
drug approval
europe
treatment outcome
orphan drug production
mercaptamine
product surveillance, postmarketing
child
ophthalmic solutions
adult
pregnancy
breast feeding
drug evaluation, preclinical
ocular cystinosis
corneal diseases
Cystine Depleting Agents
Cystine Depleting Agents
cysteamine
cystinosis

---
https://www.ema.europa.eu/medicines/human/EPAR/Dropcys
2016
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
cysteamine

---
http://www.has-sante.fr/portail/jcms/c_2561313/fr/procysbi-cysteamine-medicament-du-metabolisme
2015
false
France
French
evaluation of the transparency committee
guidelines for drug use
cysteamine bitartrate
cysteamine bitartrate
child
adult
Cystine Depleting Agents
Cystine Depleting Agents
cysteamine
cysteamine
administration, oral
Delayed-Action preparations
treatment outcome
mercaptamine
orphan drug production
cystinosis
cystine

---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=1110113&nom=Cystéamine
Canada
toxicological data sheet
cysteamine

---
https://www.ema.europa.eu/medicines/human/EPAR/Procysbi
2013
false
United Kingdom
French
English
Cystine Depleting Agents
Cystine Depleting Agents
cysteamine
cysteamine
administration, oral
Delayed-Action preparations
drug approval
treatment outcome
europe
mercaptamine
orphan drug production
cystinosis
fanconi syndrome
nephrotic syndrome
cystine
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
summary of product characteristics
package leaflet
drug evaluation
syndication feed

---
https://www.ema.europa.eu/medicines/human/EPAR/Cystagon
2007
United Kingdom
French
English
syndication feed
cystinosis
adolescent
drug approval
drug labeling
pregnancy
breast feeding
drug evaluation, preclinical
cysteamine
cysteamine
treatment outcome
drug evaluation
capsules
administration, oral
child
adult
mercaptamine
cysteamine bitartrate
cysteamine bitartrate
nephrotic syndrome
summary of product characteristics
drug evaluation
package leaflet
fanconi syndrome

---
Nous contacter.
02/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.